Physician

Anthony Robert Truxal, MD

According to 2025 Medicare claims, Anthony Truxal, MD (NPI: 1508817594) practices ophthalmology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is SOUND RETINA PS (NPI: 1700117116; TIN: 271727189) and primary practice location at 98506-9998.

Truxal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,096 traditional Medicare patients, billed 79,367 HCPCS/CPT codes, and received $3,800,227 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 226 prescription claims across 103 beneficiaries totaling $6,098 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 5 records totaling $160. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,796,817 to $3,800,227. In contrast, Part D prescription costs have fallen sharply in recent years, from $11,990 to $6,098. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2015 Medicare payment: $1,796,817 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,021,630 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,692,697 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,922,846 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,344,271 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,574,480 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,643,865 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,347,340 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,736,109 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,800,227 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201569210,124$1,796,817
20167829,787$2,021,630
20176718,156$1,692,697
20188479,043$1,922,846
20199839,578$2,344,271
202091310,665$2,574,480
202199310,154$2,643,865
20221,20217,171$3,347,340
20231,17253,241$3,736,109
20241,09679,367$3,800,227

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$24K2015 Drug cost: $11,990 (USD; Tot_Drug_Cst)2016 Drug cost: $14,290 (USD; Tot_Drug_Cst)2017 Drug cost: $23,888 (USD; Tot_Drug_Cst)2018 Drug cost: $19,987 (USD; Tot_Drug_Cst)2019 Drug cost: $22,557 (USD; Tot_Drug_Cst)2020 Drug cost: $15,091 (USD; Tot_Drug_Cst)2021 Drug cost: $13,248 (USD; Tot_Drug_Cst)2022 Drug cost: $12,749 (USD; Tot_Drug_Cst)2023 Drug cost: $7,806 (USD; Tot_Drug_Cst)2024 Drug cost: $6,098 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201591306$11,990
2016101300$14,290
2017103341$23,888
201889289$19,987
2019123381$22,557
2020101296$15,091
2021114275$13,248
2022147329$12,749
2023142277$7,806
2024103226$6,098

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye7381,767$109
92014Established patient complete exam of visual system558656$102
92134Imaging of retina7551,572$34
92250Photography of the retina602690$30
J2777Injection, faricimab-svoa, 0.1 mg40268,760$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate852,416$3,094
Ciprofloxacin HclCiprofloxacin Hcl45881$475
Brimonidine TartrateBrimonidine Tartrate15499$344
Timolol MaleateTimolol Maleate11495$91
LatanoprostLatanoprost12570$44

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$160Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anthony Robert Truxal, MD?

Tedicare shows public-source Medicare data for Anthony Robert Truxal, MD (NPI 1508817594), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Robert Truxal, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony Robert Truxal, MD?

Anthony Robert Truxal, MD is linked to SOUND RETINA PS (billing NPI 1700117116) in the available physician profile data.

Does Anthony Robert Truxal, MD have Open Payments data?

Anthony Robert Truxal, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.